Trials / Not Yet Recruiting
Not Yet RecruitingNCT07456189
The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Application of Stereotactic Body Radiotherapy (SBRT) Bridging to Allogeneic Hematopoietic Stem Cell Transplantation in Adult Hematological Malignance Patients with Extramedullary Lesions. This study aims to improve transplantation outcomes with extramedullary lesions. The investigators aim to study the Post-Transplantation Evaluation of Disease-Free Survival, Overall Survival, Treatment-Related Mortality, Cumulative Recurrence Rate, Post-Transplantation Complications, and Safety Data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic body radiotherapy (SBRT) | Stereotactic Body Radiotherapy (SBRT) before bridging to HSCT |
Timeline
- Start date
- 2026-04-14
- Primary completion
- 2028-03-01
- Completion
- 2028-03-01
- First posted
- 2026-03-06
- Last updated
- 2026-03-06
Source: ClinicalTrials.gov record NCT07456189. Inclusion in this directory is not an endorsement.